USFDA
-
Franchise India Bureau May 05 2018 - 1 min readDrug firm Zydus Cadila has received approval from the US health regulator to sell its anesthetic injection, Succinylcholine Chloride in the American market. The medication is used as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. The ...
-
Franchise India Bureau May 02 2018 - 1 min readHealth insurer Aetna Inc, which has confirmed its purchase by CVS Health Inc, reported a better-than-expected first-quarter profit, largely due to lower medical costs. U.S. drugstore operator CVS agreed in December to acquire Aetna for $69 billion seeking to tackle soaring healthcare spending through lower-cost medical services in pharmacies.
-
Franchise India Bureau Apr 24 2018 - 1 min readDr Reddy's Laboratories has confirmed to have received an establishment inspection report (EIR) from the US health regulator after an audit of its UK facility. "With regard to the audit of our API Mirfield plant, United Kingdom, we would now like to inform you that we have received an establishment inspection report (EIR) ...
-
Franchise India Bureau Apr 11 2018 - 1 min readAlembic Pharma has received approval from the US health regulator its Acyclovir a, used for the treatment of genital herpes. The company has received approval from the USFDA for its abbreviated new drug application (ANDA) Acyclovir ointment USP, 5 percent, Alembic Pharmaceuticals said in a BSE filing. The approved ...
-
Franchise India Bureau Apr 06 2018 - 1 min readDrug firm Lupin has confirmed to have received an Establishment Inspection Report (EIR) from the US health regulator for its Pithampur, Unit 1 manufacturing facility in Madhya Pradesh. The inspection was conducted in July 2017, it said in a BSE filing. USFDA gives EIR on the closure of inspection ...